【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. Global Cancer Drugs Market Outlook 2018
3.1 Cancer Incidences
3.2 Cancer Drug Market
4. Global Cancer Generics Market Analysis 2018
5. Cancer Generic Drugs Industry
5.1 Oral Generic Drugs
5.1.1 Arimidex (Anastrozole)
5.1.2 Femara (Letrozole)
5.1.3 Hycamtin (Topotecan)
5.1.4 Stivarga (Regorafenib)
5.1.5 Tarceva (Erlotinib)
5.1.6 Xalkori (Crizotinib)
5.1.7 Xeloda (Capecitabine)
5.2 Generic Injectables
5.2.1 Camptosar (Irinotecan Hydrochloride)
5.2.2 Eloxatin (Oxaliplatin)
5.2.3 Gemzar (Gemcitabine Hydrochloride)
5.2.4 Navelbine (Vinorelbine Tartrate)
5.2.5 Platinol (Cisplatin)
5.2.6 Taxol (Paclitaxel)
5.2.7 Taxotere (Docetaxel)
6. Cancer Generics Market: Major Indications
6.1 Lung Cancer
6.1.1 Incidence Outlook
6.1.2 Commercialized Drugs
6.2 Breast Cancer
6.2.1 Incidence Outlook
6.2.2 Commercialized Drugs
6.3 Colorectal Cancer
6.3.1 Incidence Outlook
6.3.2 Commercialized Drugs
6.4 Stomach Cancer
6.4.1 Incidence Outlook
6.4.2 Commercialized Drugs
6.5 Prostate Cancer
6.5.1 Incidence Outlook
6.5.2 Commercialized Drugs
7. Market Dynamics
7.1 Indian Generic Cancer Drug Introduced in the US Market
7.2 Launch of Generic Drugs for Oncology
7.3 Increasing Cancer Burden Paving Way for Generics
7.4 Patent Expiry of Blockbuster Oncology Drugs
7.5 Strategic Collaborations
8. Key Players
8.1 Fresenius Kabi AG
8.1.1 Business Overview
8.1.2 Key Financials
8.1.3 Strategic Developments
8.2 Actavis Plc.
8.2.1 Business Overview
8.2.2 Key Financials
8.2.3 Strategic Developments
8.3 Hospira
8.3.1 Business Overview
8.3.2 Key Financials
8.3.3 Strategic Developments
8.4 Teva Pharmaceutical Industries Ltd.
8.4.1 Business Overview
8.4.2 Key Financials
8.4.3 Strategic Developments
8.5 Mylan
8.5.1 Business Overview
8.5.2 Key Financials
8.5.3 Strategic Developments
8.6 Sun Pharmaceuticals
8.6.1 Business Overview
8.6.2 Key Financials
8.6.3 Strategic Developments
List of Figures:
Figure 3-1: Global – Number of New Cancer Cases (Million), 2012 & 2025
Figure 3-2: Global – Cancer Incidences by Gender (Million), 2012
Figure 3-3: Global – Cancer Drugs Market (Billion US$), 2008-2013
Figure 3-4: Global – Cancer Drugs Market (Billion US$), 2014-2018
Figure 3-5: Cancer Drugs Market Share by Geography (%), 2013
Figure 3-6: Cancer Drugs Market Share by Geography (%), 2018
Figure 3-7: Global – Cancer Treatment Modalities Revenue Share (%), 2013
Figure 4-1: Global – Cancer Generics Market (Billion US$), 2013-2018
Figure 6-1: Global – Number of New Lung Cancer Cases (Million), 2012 & 2020
Figure 6-2: Global – Forecast for New Lung Cancer Cases by Region (%), 2020
Figure 6-3: Global – Number of New Breast Cancer Cases (Million), 2012 & 2020
Figure 6-4: Global – Forecast for New Breast Cancer Cases by Region (%), 2020
Figure 6-5: Global – Number of New Colorectal Cancer Cases (Million), 2012 & 2020
Figure 6-6: Global – Forecast for New Colorectal Cancer Cases by Region (%), 2020
Figure 6-7: Global – Number of New Stomach Cancer Cases (Million), 2012 & 2020
Figure 6-8: Global – Forecast for New Stomach Cancer Cases by Region (%), 2020
Figure 6-9: Global – Number of New Prostate Cancer Cases (Million), 2012 & 2020
Figure 6-10: Global – Forecast for New Prostate Cancer Cases by Region (%), 2020
Figure 8-1: Fresenius Kabi – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-2: Fresenius Kabi – Revenue Share by Region (%), 2013
Figure 8-3: Fresenius Kabi – Revenue Share by Business Segment (%), 2013
Figure 8-4: Actavis – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-5: Actavis – Revenue Share by Region (%), 2013
Figure 8-6: Actavis – Revenue Share by Business Segment (%), 2013
Figure 8-7: Hospira – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-8: Hospira – Revenue Share by Region (%), 2013
Figure 8-9: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-10: Teva – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-11: Teva – Revenue Share by Region (%), 2013
Figure 8-12: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-13: Mylan – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-14: Mylan – Revenue Share by Region (%), 2013
Figure 8-15: Mylan – Revenue Share by Business Segment (%), 2013
Figure 8-16: Sun Pharma – Sales & Net Income (Billion US$), 2012-13/ 2013-14
Figure 8-17: Sun Pharma – Revenue Share by Business Segment (%), 2013-14
List of Tables:
Table 3-1: Most Prevalent Types of Cancer
Table 3-2: Top 10 Countries with Highest Cancer Prevalence Rates
Table 5-1: List of Companies Dealing in Generic Arimidex
Table 5-2: Cost Comparison of Generics and Branded Arimidex (Anastrozole)
Table 5-3: List of Companies Dealing in Generic Femara
Table 5-4: Cost Comparison of Generics and Branded Femara (Letrozole)
Table 5-5: List of Companies Dealing in Generic Hycamtin
Table 5-6: List of Companies Dealing in Generic Xeloda
Table 5-7: Cost Comparison of Generics and Branded Xeloda (Capecitabine)
Table 5-8: List of Companies Dealing in Generic Camptosar
Table 5-9: Cost Comparison of Generics and Branded Camptosar (Irinotecan Hydrochloride)
Table 5-10: List of Companies Dealing in Generic Gemzar (Gemcitabine Hydrochloride)
Table 5-11: Cost Comparison of Generics and Branded Gemzar (Gemcitabine Hydrochloride)
Table 5-12: List of Companies Dealing in Generic Navelbine (Vinorelbine)
Table 5-13: Cost Comparison of Generics and Branded Navelbine (Vinorelbine)
Table 5-14: List of Companies Dealing in Generic Platinol (Cisplatin)
Table 5-15: List of Companies Dealing in Generic Taxol (Paclitaxel)
Table 5-16: Cost Comparison of Generics and Branded Taxol (Paclitaxel)
Table 5-17: List of Companies Dealing in Generic Taxotere (Docetaxel)
Table 5-18: Cost Comparison of Generics and Branded Taxotere (Docetaxel)
Table 6-1: Top 10 Countries by Lung Cancer Incidences (2012)
Table 6-2: Global – Key Lung Cancer Drugs and Patent Expiry Status
Table 6-3: Top 10 Countries by Breast Cancer Incidences (2012)
Table 6-4: Global – Key Breast Cancer Drugs and Patent Expiry Status
Table 6-5: Top 10 Countries by Colorectal Cancer Incidences (2012)
Table 6-6: Global – Key Colorectal Cancer Drugs and Patent Expiry Status
Table 6-7: Top 10 Countries by Stomach Cancer Incidences (2012)
Table 6-8: Global – Key Stomach Cancer Drugs and Patent Expiry Status
Table 6-9: Top 10 Countries by Prostate Cancer Incidences (2012)
Table 6-10: Global – Key Prostate Cancer Drugs and Patent Expiry Status
Table 7-1: Global – Key Cancer Drugs and Patent Expiry Status
Table 8-1: Fresnius Kabi Pharmaceuticals – Key Cancer Generic Drugs
Table 8-2: Actavis – Key Cancer Generic Drugs
Table 8-3: Hospira – Key Cancer Generic Products
Table 8-4: Teva Pharmaceuticals – Key Cancer Generic Drugs
Table 8-5: Mylan – Key Cancer Generic Drugs
Table 8-6: Sun Pharmaceuticals – Key Cancer Generic Drugs
【レポート販売概要】
■ タイトル：世界の癌治療用ジェネリック医薬品市場■ 英文：Global Cancer Generics Market Outlook 2018
■ 発行日：2014年8月
■ 調査会社：RNCOS
■ 商品コード：RNCS4087
■ 調査対象地域：グローバル
- 世界のモバイル3D市場The past decade witnessed a giant leap in the entertainment industry, with 3Dl motion pictures trickling out of cinemas to 3D television screens. New generation 3D mobile phones are next to follow suit, without the need for 3D viewing glasses. With an increasing number of mobile applications and technologies being produced, 3D capture is likely to become as important as 3D viewing in TVs. Mobile p …
- エアロゲルの世界市場：シリカエアロゲル、ポリマーエアロゲル、カーボンエアロゲルAerogel is an advanced high-performance insulation material that has high load-bearing capacity with high resistance to thermal, flame, moisture, sound, and weather. These unique properties find applications for aerogel, such as oil & gas, construction, automotive, marine, & aerospace, performance coating, day-lighting & LVHS among others. The market for aerogel is estimated to grow on account of …
- 世界のグリーン建設（緑の建築）市場動向• The report presents an in-depth analysis of industry executives’ opinions about the adoption of green construction • The report identifies key reasons for companies not to undertake green construction projects • The report highlights the key priorities of industry executives with regards to the transformation of green construction activities in their future construction projects • The report asc …
- 日本の癌診断・検査市場2014This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Table of ContentsBusiness EnvironmentMarket StructureMarket Size, Growth, and Major Suppliers' Market SharesList of TablesTest Volume Forecasts by Market Segment …
- 小型UAV（無人航空機）の世界市場：マイクロUAV、ミニUAV、ナノUAVThe wide variety of applications in which small unmanned aerial vehicles (UAVs) can be deployed is growing every day, as this growth-platform finds new uses The demand for small UAVs will be significant, with a wide and varied geographical spread. This growth is forecast to vary country-by-country and by design type. Understanding these dynamics – particularly the variations and intricacies the ma …
- 学校向けERPソフトウェアの世界市場2015-2019School ERP software solutions ERP software refers to business management solutions that enable organizations integrate business operations, such as product planning, product development, manufacturing processes, inventory control, and distribution for optimal management. ERP software catering to the needs and requirements of schools has attracted the attention of the education sector. Various modu …
- 位置情報基盤のモバイルマーケティングソリューション分析と予測2013-2018（Mobile Location-based Marketing Solutions Analysis and Market Forecast 2013-2018）Location-Based Marketing (LBM) is a form of mobile marketing that delivers mobile display banner ads, paid search ads, and other forms of ads directly to user handsets often within proximity of point-of-sale (POS) location. Mobile location based advertising is also increasing and will be almost 65% of total mobile advertising revenue by 2018. LBM is expected to grow 150% by 2020 and location based …
- PT Pertamina (Persero)：石油・ガスバリューチェーン分析レポート2013PT Pertamina (Persero) Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "PT Pertamina (Persero)" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “PT Pertamina (Persero)”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- アメリカのモバイル端末向けハプティック技術市場About haptic technology Haptics or haptic technology is a tactile feedback technology that uses the sense of touch by applying forces and vibrations motions to a user. Through this technology, end-users are able to perceive touch sensations when using electronic devices. Haptics are enabled by actuators that are embedded in a device, and it makes the user experience more physical and realistic. Ha …
- 癌治療用バイオシミラーの世界市場：抗がん剤、支持療法About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopha …
- 救急箱の世界市場2017-2021About First Aid KitFirst aid kits are an essential part of safety precaution from unexpected injuries during work, traveling, sports and recreational activities. Global market for first aid kits is driven by increasing demand from sports industry. Increasing consumption of first aid kits in commercial buildings and industrial work sites due to the increasing safety regulations and self-awareness r …
- 帯電防止剤の世界市場予測（～2021年）：エトキシル化脂肪酸アミン、グリセロールモノステアレート、ジエタノールアミンAntistatic agents are added to polymers in order to remove or reduce the static charge that has accumulated over their surface. Antistatic agents are divided into external and internal agents, based on their applicability. Internal antistatic agents are directly incorporated into the material, whereas, external antistatic agents are applied over the surface of materials. The antistatic agents mark …
- ディスクリート・ダイオードの世界市場2017-2021About Discrete DiodeThe discrete diodes are semiconductor components that allow the current to pass from one direction (with zero resistance) and not from another direction (offering almost infinite resistance). Technavio’s analysts forecast the global discrete diode market to grow at a CAGR of 4.6% during the period 2017-2021. [Covered in this report] The report covers the present scenario and th …
- 2014年戦略提言：スペインの内分泌機能検査市場This new 271-page report from Venture Planning Group provides a comprehensive analysis in the Spanish endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Est …
- 末梢血管装置（医療機器）のグローバル市場（2012-2018）Global Peripheral Vascular Devices sector forecasts to reach US$5 billion by 2016 at a CAGR of 10.8% during the analysis period 2012-2018. North American region accounts for highest percentage approximately 42% (2015) of global share while Europe follows next with nearly 27.7% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 12.5% driving a market value of US$1 billi …
